ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,048.42
      -0.46%
      US Tech 100
      17,137.20
      0.94%
      Dow Jones
      38,085.80
      -0.98%
      Brent Oil
      88.275
      0.14%
      Bitcoin
      64,420.22
      -0.10%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Nuvalent Inc (NUVL)

      7. Nuvalent Inc (NUVL) News

      NUVL Nuvalent Inc

      66.07
      0.00 (0.00%)
      Pre Market
      Last Updated: 04:05:14
      Delayed by 15 minutes
      Company Name Stock Ticker Symbol Market Type
      Nuvalent Inc NUVL NASDAQ Common Stock
        Price Change Change Percent Stock Price Last Traded
      Upgrade Icon
      0.00 0.00% 66.07 04:05:14
      Open Price Low Price High Price Close Price Prev Close
      66.07
      more quote information »

      Recent News

      Date Time Source Heading
      4/25/20248:52IHNWFeaturedCannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA
      4/08/202416:30PRNUSNuvalent Presents New Preclinical Data Supporting Profiles..
      3/05/202416:52PRNUSNuvalent to Present New Preclinical Data on HER2-Selective..
      2/27/202407:00EDGAR2Form S-8 - Securities to be offered to employees in employee..
      2/27/202406:42EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
      2/27/202406:38EDGAR2Form 8-K - Current report
      2/27/202406:30PRNUSNuvalent Highlights Pipeline Progress, Reiterates Key..
      2/27/202406:15PRNUSNuvalent Receives U.S. FDA Breakthrough Therapy Designation..
      2/12/202406:30PRNUSNuvalent Initiates the Phase 2 Portion of ALKOVE-1 Clinical..
      2/01/202406:30PRNUSNuvalent to Participate in the Guggenheim Healthcare Talks..
      1/09/202416:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/09/202416:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/09/202416:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/09/202416:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/09/202416:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/09/202416:40EDGAR2Form 8-K - Current report
      1/08/202406:30PRNUSNuvalent Announces "OnTarget 2026" Operating Plan and Key..
      12/28/202317:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      12/26/202316:31EDGAR2Form 144 - Report of proposed sale of securities
      12/21/202306:30PRNUSNuvalent to Present at the 42nd Annual J.P. Morgan..
      12/20/202316:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      12/20/202316:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      12/20/202316:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      12/19/202318:00EDGAR2Form 144 - Report of proposed sale of securities
      12/18/202317:45EDGAR2Form 144 - Report of proposed sale of securities
      12/18/202317:32EDGAR2Form 144 - Report of proposed sale of securities
      12/18/202317:23EDGAR2Form 144 - Report of proposed sale of securities
      11/30/202316:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      11/14/202306:50EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
      11/14/202306:45EDGAR2Form 8-K - Current report
      11/14/202306:30PRNUSNuvalent Highlights Corporate and Pipeline Achievements and..
      11/03/202316:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      11/01/202306:30PRNUSNuvalent to Participate in the BMO Virtual BioPharma..
      10/26/202316:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      10/24/202318:01EDGAR2Form 144 - Report of proposed sale of securities
      10/17/202316:07EDGAR2Form 8-K - Current report
      10/17/202316:05EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
      10/16/202321:55PRNUSNuvalent Announces Pricing of Public Offering of Common..
      10/16/202307:39EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
      10/16/202307:30PRNUSNuvalent Announces Public Offering of Common Stock
      10/13/202306:40EDGAR2Form 8-K - Current report
      10/13/202306:30PRNUSNuvalent Reports Preliminary Phase 1 Clinical Data from..
      10/06/202316:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      10/06/202316:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      10/04/202316:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      10/04/202316:12EDGAR2Form 144 - Report of proposed sale of securities
      10/04/202316:05EDGAR2Form 8-K - Current report
      10/04/202312:21PRNUSPreliminary Phase 1 Dose-Escalation Data from ALKOVE-1 Trial..
      9/19/202316:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      9/18/202306:30PRNUSNuvalent to Present Preliminary Data from ALKOVE-1 Phase 1/2..
      9/06/202316:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..

      Your Recent History

      NASDAQ
      NUVL
      Nuvalent
      Delayed Upgrade Clock